BDNF and post-traumatic stress disorder: Further, the identification of a human BDNF SNP that is resistant to the protective effects of prophylactic (R,S)-ketamine may also inform future PTSD-related clinical studies aimed at assessing the efficacy of prophylactic (R,S)-ketamine treatment based on the patient’s unique genetic background.